Showing 20 of 98 recruiting trials for “squamous-cell-carcinoma-of-the-lip”
A Multicenter Trial of YSQTG vs. Simulated Agents With Neoadjuvant Chemoradiotherapy or Chemoimmunotherapy for EC
👨⚕️ Li Feng, Ph.D., Cancer Institute and Hospital, Chinese Academy of Medical Sciences📍 1 site📅 Started Aug 2024View details ↗
Neoadjuvant Radiochemotherapy Combined With Cadonilizumab for Local Advanced Esophageal Squamous Cell Cancer
👨⚕️ Xiangbo Wan, The First Affiliated Hospital of Zhengzhou University📍 1 site📅 Started Aug 2024View details ↗
Adbelimumab Combined With Chemotherapy and Apatinib in Patients With Resectable Esophageal Squamous Cell Carcinoma
👨⚕️ Wang, 2nd Affiliated Hospital, School of Medicine, Zhejiang University📍 1 site📅 Started Aug 2024View details ↗
Neoadjuvant Camrelizumab With Palbociclib for Resectable Esophageal Squamous Cell Carcinomas
Immunochemotherapy ± Salvage Chemoradiation for Local Recurrence of Esophageal Squamous Cell Carcinoma After Definitive Chemoradiotherapy
Biomarker Based Neoadjuvant Strategies for Locally Advanced Resectable ESCC
Neoadjuvant PD-1 Blockade for Elderly Esophageal Squamous Cell Carcinoma (BLESS)
Efficacy and Safety of Adebrelimab Combined With Chemoradiotherapy in Patients With Unresectable Locally Advanced or Postoperative Recurrent Esophageal Squamous Cell Carcinoma
Sintilimab After Concurrent Chemoradiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma
PPIO-008 Tislelizumab Combined With S-1 in Patients With ypT+N0 ESCC After Radical Resection With Neoadjuvant STUDY
🏥 Daping Hospital and the Research Institute of Surgery of the Third Military Medical University📍 1 site📅 Started May 2024View details ↗
Adebrelimab ±Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Unresectable Locally Advanced ESCC
👨⚕️ Yong Yang, Doctor, Fujian Medical University Union Hospital📍 1 site📅 Started Apr 2024View details ↗
RecruitingNCT06698692 ↗
Trilaciclib for the Prevention of Chemoradiotherapy-Induced Myelosuppression in Esophageal Squamous Cell Carcinoma
👨⚕️ Xiao L Ge, PHD, The First Affiliated Hospital with Nanjing Medical University📍 1 site📅 Started Apr 2024View details ↗
Fruquintinib in Combination With Tislelizumab Followed by Radiotherapy in Esophageal Squamous Cell Carcinoma
Combination Immunotherapy of Adebrelimab With Apatinib and Tegafur for Immune Rechallenge Therapy in Esophageal Squamous Cell Carcinoma
A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
Consolidation of Toripalimab After Chemoradiotherapy in Elderly Esophageal Cancer (EC-CRT-007)
Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy
RecruitingNCT06408584 ↗
Short-course Hypofractionated Radiotherapy in Combination With Raltitrexed and Tislelizumab
Neoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative Radioimmunotherapy
RecruitingNCT06169163 ↗
Volatile Organic Compounds as Breath Biomarkers in Squamous Oesophageal Neoplasms
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →